<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DELAVIRDINE MESYLATE</span><br/>(del-a-vir'deen)<br/><span class="topboxtradename">Rescriptor<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antiviral</span>; <span class="classification">nonnucleoside reverse transcriptase inhibitor</span><br/><b>Prototype: </b>Efavirenz<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Nonnucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 binds directly to reverse transcriptase (RT) and blocks RNA-
         and DNA-dependent DNA polymerase activities.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Thus, it prevents replication of the HIV-1 virus. HIV-2 RT and human DNA polymerases such as polymerases alpha, gamma, and
         delta are not inhibited by delavirdine. Resistant strains appear rapidly.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of HIV infection in combination with other antiretroviral agents.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to delavirdine; lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired liver function, pregnancy (category C). Safety and efficiency in children <img src="../images/special/lesserorequal.gif"/>16
         y have not been established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">HIV Infection</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 400 mg t.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <img src="../images/special/lesserorequal.gif"/><i>16 y</i>, 400 mg t.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Disperse in water by adding a single dose to at least 3 oz of water, let stand for a few minutes, then stir to create a uniform
            suspension just prior to administration.
         </li>
<li>Give drug to patients with achlorhydria with an acid beverage such as orange or cranberry juice.</li>
<li>Store at 20°25° C (68°77° F) and protect from high humidity in a tightly closed container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Headache, fatigue, allergic reaction, chills, edema, arthralgia. <span class="typehead">CNS:</span> Abnormal coordination, agitation, amnesia, anxiety, confusion, dizziness. <span class="typehead">CV:</span> Chest pain, bradycardia, palpitations, postural hypotension, tachycardia. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, increased LFTs, abdominal cramps, anorexia, aphthous stomatitis. <span class="typehead">Hematologic:</span>
<span class="speceff-life">Neutropenia</span>. <span class="typehead"> Respiratory:</span>  Bronchitis, cough, dyspnea. <span class="typehead">Skin:</span>
<span class="speceff-common">Rash,</span> pruritus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">antacids</span>, <span class="classification">h<sub>2</sub>-receptor antagonists</span> decrease absorption; <b>didanosine</b> and <b>delavirdine</b> should be taken 1 h apart to avoid decreased delavirdine levels; <b>clarithromycin,</b>
<b>fluoxetine,</b>
<b>ketoconazole</b> may increase delavirdine levels; <b>carbamazepine,</b>
<b>phenobarbital,</b>
<b>phenytoin,</b>
<b>rifabutin,</b>
<b>rifampin</b> may decrease delavirdine levels; delavirdine may increase levels of <b>clarithromycin,</b>
<b>indinavir,</b>
<b>saquinavir,</b>
<b>dapsone,</b>
<b>rifabutin,</b>
<b>alprazolam,</b>
<b>midazolam,</b>
<b>triazolam,</b>
<span class="classification">dihydropyridine</span>, <span class="classification">calcium channel blockers</span> (e.g., <b>nifedipine,</b>
<b>nicardipine,</b> etc.), <b>quinidine,</b>
<b>warfarin.</b>
<span class="typehead">Herbal:</span>
<b>St. John's wort</b> may decrease antiretroviral activity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract, 80% reaches systemic circulation. <span class="typehead">Peak:</span> 1 h. <span class="typehead">Distribution:</span> 98% protein bound. <span class="typehead">Metabolism:</span> Metabolized in the liver by the CYP3A enzymes. <span class="typehead">Elimination:</span> Approximately 51% excreted in urine, 44% in feces. <span class="typehead">Half-Life:</span> 211 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Therapeutic effectiveness: Indicated by decreased viral load.</li>
<li>Monitor for and immediately report appearance of a rash, generally within 13 wk of starting therapy; rash is usually
            diffuse, maculopapular, erythematous, and pruritic.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take this drug exactly as prescribed. Missed doses increase risk of drug resistance.</li>
<li>Do not take antacids and delavirdine at the same time; separate by at least 1 h.</li>
<li>Report all prescription and nonprescription drugs used to physician because of multiple drug interactions.</li>
<li>Discontinue medication and notify physician if rash is accompanied by any of the following: Fever, blistering, oral lesions,
            conjunctivitis, swelling, muscle or joint pain.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>